We are thrilled to announce a significant milestone in the journey of GlycanAge, one of the pioneering startups in the field of personalised preventative healthcare. Through our P4SY accelerator programme, we’ve had the privilege of supporting GlycanAge as they navigate the complexities of glycan biomarkers and push the boundaries of scientific innovation.

GlycanAge recently announced the successful completion of their €3.9 million seed funding round, led by LAUNCHub Ventures and Kadmos Capital. This substantial investment underscores the immense promise of their work in advancing glycomics and precision medicine.

At the helm of GlycanAge are CEO Nikolina Lauc and Chief Scientific Officer Dr. Gordan Lauc, whose visionary leadership has propelled the company forward. With decades of combined experience and a passion for transforming healthcare, they are reshaping the landscape of preventative medicine.

The field of glycobiology holds immense potential in predicting diseases, guiding interventions, and tailoring therapies. Yet, it has historically faced challenges due to scientific complexities and the absence of necessary technologies. GlycanAge is changing this narrative by harnessing breakthroughs in technology to unlock the power of glycan biomarkers.

Their cutting-edge biological age test, developed over years of research and supported by €40 million in grant funding, offers early prevention strategies for both consumers and healthcare professionals. By leveraging glycan biomarkers, GlycanAge aims to empower individuals to take control of their well-being and redefine the future of healthcare.

This funding round marks a strategic shift for GlycanAge from the longevity space to the broader diagnostics market. With a focus on developing disease-specific prognostic biomarkers, they are poised to make a significant impact on healthcare outcomes.

We are proud to have played a part in GlycanAge’s journey and excited to continue supporting them as they pave the way for a healthier future. Congratulations to the entire GlycanAge team on this remarkable achievement! We look forward to witnessing the transformative impact of their work on the world of healthcare.

Original post: https://www.eu-startups.com/2024/02/croatian-longevity-startup-glycanage-secures-e3-9-million-to-advance-personalized-preventative-care/